Related Experiment Video
Updated: Jul 12, 2026

Classical Short-Delay Eyeblink Conditioning in One-Year-Old Children
Published on: September 1, 2018
UK collaborative randomised trial of neonatal extracorporeal membrane oxygenation: follow-up to age 4 years
Insights
Extracorporeal membrane oxygenation (ECMO) improved survival and outcomes for infants with respiratory failure. Long-term follow-up at age 4 showed favorable results for ECMO support compared to conventional care.
Area of Science:
- Neonatal intensive care
- Pediatric respiratory support
- Extracorporeal membrane oxygenation
Background:
- Acute respiratory failure is a critical condition in neonates.
- Extracorporeal membrane oxygenation (ECMO) offers advanced life support.
- Limited long-term data exists for neonatal ECMO outcomes.
Purpose of the Study:
- To evaluate long-term morbidity at age 4 years in survivors of neonatal ECMO.
- To compare ECMO support with contemporary conventional care in neonates.
- To assess the safety and efficacy of neonatal ECMO.
Main Methods:
- Prospective cohort study of infants receiving ECMO.
- Follow-up assessment at 4 years of age for morbidity.
- Comparison of ECMO group with a control group receiving conventional care.
Main Results:
- Neonatal ECMO policy demonstrated improved survival rates.
- Survivors of ECMO showed favorable long-term outcomes at age 4.
- ECMO was associated with a positive overall outcome compared to conventional care.
Conclusions:
- Neonatal ECMO is a safe and effective intervention for acute respiratory failure.
- The UK Collaborative ECMO Trial provides crucial long-term data.
- ECMO support is advocated for critically ill neonates requiring intensive care.
Abstract:
Extracorporeal membrane oxygenation (ECMO) is a supportive intensive-care technique used for babies with acute respiratory failure. We examined morbidity at age 4 years in surviving children recruited to the UK Collaborative ECMO Trial, and provide long-term data on ECMO support compared with contemporary conventional care. The neonatal ECMO policy resulted in improved survival and a favourable outcome. We therefore advocate the safety and efficacy of this intervention.

